200 Summit Lake Drive
130 articles with FUJIFILM
Fujifilm Sonosite Receives FDA COVID-19 510(k) Clearance for Comprehensive Point-of-Care Ultrasound Portfolio
FUJIFILM Sonosite , Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, today announced that the company has received 510(k) Clearance from the U.S. Food & Drug Administration (FDA) for the company's entire POCUS portfolio to sup
FUJIFILM Sonosite Launches New Point-Of-Care Ultrasound System With Adaptable Form Factor, Embedded Workflow, And The Most Advanced Image Clarity Sonosite Has Ever Offered
FUJIFILM Sonosite, Inc. , specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, has announced the launch of the new Sonosite PX ultrasound system. Sonosite PX is the next generation in Sonosite POCUS, with the most advanced image clarity ever seen in
Dr. Reddy’s Partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a Potential Treatment of COVID-19
Dr. Reddy's Laboratories Ltd. announces partnering with FUJIFILM Corporation through FUJIFILM Toyama Chemical Co. Ltd. and Global Response Aid for the development, manufacture and sales of Avigan® Tablets, a potential treatment of COVID-19.
Fujifilm to invest 100 billion yen (928 million USD) to expand its large scale biologics production facility in Denmark
FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen in the Denmark site of FUJIFILM Diosynth Biotechnologies, a leading contract development and manufacturing organization for biologics and advanced therapies.
Health Canada Clears Appili Therapeutics’ Phase 2 Clinical Trial Evaluating Favipiravir as a Prophylactic Agent Against COVID-19 Outbreaks
Appili Therapeutics Inc., a biopharmaceutical company focused on anti-infective drug development, announced that Health Canada provided regulatory clearance for Appili’s Phase 2 study evaluating FUJIFILM Toyama Chemical’s favipiravir as a preventative measure against COVID-19 outbreaks.
Fabian, President and COO of FUJIFILM Sonosite, Inc., applauds AdvaMed for its leadership in times of health crisis
Appili Therapeutics Submits CTA with Health Canada to Sponsor Prophylactic Phase 2 Clinical Trial Evaluating FUJIFILM Toyama Chemical’s Favipiravir as a Preventative Measure Against COVID-19 in Canadian Long-Term Care Facilities
First clinical program in the world designed to assess the use of favipiravir for COVID-19 as prophylaxis for outbreak control; antiviral drug has shown early efficacy against COVID-19
CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug “Avigan® Tablet” and Contributes to Accelerating Provision for COVID-19 Patients
CMIC HOLDINGS Co., Ltd. announced that CMIC is providing monitoring services as a CRO for “Avigan® Tablet”, a product that FUJIFILM Toyama Chemical Co., Ltd. gained approval in Japan for manufacture and sale as an influenza antiviral drug, phase III clinical trial in Japan and will support for manufacturing the product as a CDMO..
FUJIFILM Corporation has announced that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its influenza antiviral drug "Avigan® Tablet" for treating patients with COVID-19..
3/20/2020Companies strengthen their leadership teams and board with this week's Movers & Shakers.
FujiFilm itself has not commented on the reports from China, The Guardian noted.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 19, 2020.
SMART Medical Systems Launches its G-EYE® 760R Colonoscope in the European Endoscopy Market Through FUJIFILM Europe, Under Strategic Distribution Partnership With FUJIFILM, to Provide Synergetic Colonoscopy Solution in Fight Against Colon Cancer
SMART's G-EYE® 760R colonoscope, incorporating its G-EYE® Balloon Technology designed to increase the detection of cancerous polyps in colonoscopy, will become available by FUJIFILM Europe with its state-of-the-art ELUXEO system, as part of the newly formed strategic distribution partnership with FUJIFILM Corporation.
FUJIFILM Corporation Announces Plans For Operating Room And Interventional Systems Integration Business
Industry leader to present the market with a one-stop, single-vendor solution for medical image capture, management, storage, and image enablement
FUJIFILM Corporation will invest 13 billion yen (about $120 million) to expand the company’s gene therapy business and establish a new Gene Therapy Innovation Center adjacent to its current facility in College Station, Texas and add about 100 jobs.
Fujifilm announces expansion of its biopharmaceutical contract development and manufacturing business capital investment totaling approximately 13 billion yen committed to expand gene therapy capabilities
Establishing a New Gene Therapy Drug Process Development Building and Expanding Product Facilities in Texas, USA
Company demonstrates suite of imaging and educational solutions to more than 14,000 anesthesia professionals
FUJIFILM SonoSite, Inc. Signs Agreement With Intelligent Ultrasound Group plc To Develop Clinician Training
The agreement includes Intelligent Ultrasound Group's BodyWorks Eve POCUS training solution and the HeartWorks transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) simulator training platforms that can be used to accelerate training for all Fujifilm SonoSite's POCUS systems.
Industry leader presents two new pulmonary imaging devices
FUJIFILM Corporation announced that it has completed the acquisition of Biogen Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark from Biogen.